03/12/2011 by MidPharma

MIDPHARMA…

MIDPHARMA – MIDDLE EAST PHARMACEUTICAL & CHEMICAL INDUSTRIES COMPANY

Midpharma is Public Shareholding Company founded in 1993 and commenced production by the end of 1997. Midpharma currently produces Antibiotics, Analgesics-Antipyretics, Vitamins, Haematinics, Cardiovascular preparations, Hypoglycemics, Antiulcerants, and Antifungals.

In 2005, Midpharma has acquired new product lines consisting of deramatologicals, local analgesics, topical nasal decongestants, topical anti-hemorrhoidals, gynaecological anti-infectives, and laxatives.

Midpharma’s production site is spread over 35,000 m2 consisting of a general plant and a cephalosporin’s plant with production lines consisting of tablet, capsule, aerosol, suppository, ointment, liquid, dry-suspension, and counting. Midpharma holds European Good Manufacturing Practice (GMP) for solid dosage form in general formulation as well as Jordanian GMP for both plants. We are also ISO9001:2000 certified.

Midpharma’s manufacturing strengths made it a world-class producer of branded generics.Midpharma’s products are registered and actively sold in all the major Middle East and North African markets.

Midpharma differentiates itself by successfully managing profitable growth whilst maintaining customer responsiveness. The leadership and staff are totally committed to quality and are continually on the look out for further development.

03/12/2011 by MidPharma

A WORD FROM THE CHAIRMAN..

These are certainly challenging times for us. Since becoming part of TANTASH, we have a broader portfolio, a stronger pipeline and healthier finances. We are constantly looking for new ways to grow and develop our company. The recent acquisition of Arab Center (ACPC) lines has opened Midpharma to be an active OTC player. We are also expanding our contract manufacturing business so that we can really take advantage of these new opportunities.

We are ambitious and have an appetite for success. Our goal is to become together with our partners and distributtors a regional leader of first class generics. This is not just about being the first choice of practitioners; it is also about having an innovative marketing approach and having the very best people on Midphrma’s staff.

http://101topbusinessleaders.blogspot.com/2011/01/mr-tantash-mazen-ceo-chairman-tantash.html

03/12/2011 by MidPharma

VISION & MISSION…

OUR VISION

MIDPHARMA actively seeks to evoke an effective image of a quality pharmaceutical producer among consumers, practitioners, and regulatory authorities ensuring that all of its products are of quality and add value to the medical community.

OUR MISSION

We at MIDPHARMA are dedicated to achieve competitive growth through delivering products of high standards that will help cure people around the world. We do this by recuiting, developing, nurturing and empowering the best skilled staff and applying innovative management approaches. By doing this we are confidant that our outstanding performance will reward those who invest in our company.

03/12/2011 by MidPharma

COMPANY BRIEF…

MIDPHARMA is Public Shareholding Company Founded in 1993 and commenced production by the end of 1997. MIDPHARMA within a relatively short time has been able to offer one of the broadest product portfolios and pipline in the jordanian industry, having over than 200 medicines available and about 50 in the development area.

With its modern infrastructure located in Amman, MIDPHARMA is specialized in the production and packaging of generics in many pharmaceutical forms. The unit produces proprietary products and conducts contract manufacturing for third parties.

From the time of its inception, MIDPHARMA has specialized in the manufacturing of pharmaceutical products based on highest standards of raw materials. MIDPHARMA ‘s manufacturing strengths made it a world-class producer of branded generics that are registered and actively sold in sixteen countries .

At MIDPHARMA we are committed to continually provide first class pharmaceuticals and introducing them in our active markets in the shortest possible time and at the same time carry on to offer our customers a high service level. This is the spirit, on which MIDPHARMA bases its promise to produce and develop all of its products and therefore the company has gained a respectfull market position.

MIDPHARMA differentiates itself by successfully managing profitable growth whilst maintaining agile customer responsiveness.

The leadership and staff are totally committed to quality and are always looking out for further development.

03/12/2011 by MidPharma

OUR FACILITIES…

MIDPHARMA’s site is located 20 kilometers north of Amman near the town of mubis and about 1.5 kilometers from the main highway to the ancient city of Jerash. Our production site is spread over 35,000 m² consisting of a general plant and a cephalosporins plant .

MIDPHARMA hold European Good Manufacturing Practice (cGMP) for solid dosage forms in general formulation as well as Jordanian GMP for both plants. We are also ISO 9001:2000 certified.

Our manufacturing complix consists of the following :

General plant 4,800 square meters
Cephalosporins plant 2,800 square meters
Warehousing area 2,500 square meters
Laboratories and other support facilities 2,400 square meters

The currently built area is 12,500 square meters with plenty of land space for future expansion.

MIDPHARMA prides itself for being the first company in Jordan to have FDA approval for the plants ’ layout and design and for having a totally separate cephalosporin’s plant.

03/12/2011 by MidPharma

PRODUCTS LINES…

MIDPHARMA manufactures a wide range of pharmaceutical lines:

Antiulcerants
Antibiotics
Antihypertensives
Hypolipidimics
Erectile Dysfunction Medications
Antidiabetics
Analgesics & Anti-inflammatory Agents
Multivitamins & Minerals
Benign Prostatic Hyperplasia Medications
Antifungals
CNS Preparations
Antihistamines
Antianaemics

Oral Antivirals
Antilice & Scabicides
Disinfectants & Cleansing Agents
Nasal Decongestants
Laxatives
Antithesis & Cough Suppressants
Antiseptic Oropharyngeals
Gynaecology Anti-Infectives
Contraceptive Spermicidals

Dermatological Preparations

Topical Plain Steroids
Topical Steroids & Anti-Infectives
Topical Plain Anti-Infectives
Topical Antifungals
Topical Steroids & Antifungals
Topical Antivirals
Topical Antipsoriasis
Topical Antipruritics
Local Anaesthetics & Antiseptics
Bby Care
Antihemorrhoidals
Local Analgesics, Rubefacients & Counterirritants
Keratolytics
Antiseptics

03/12/2011 by MidPharma

BUSINESS & RESEARCH DEVELOPMENT…

BUSINESS DEVELOPMENT

MIDPHARMA is a multi-specialty branded-generics company, offering the generics industry a complete service range from product development and registration through to sourcing, manufacturing, packaging and logistics.

MIDPHARMA’s Business Development identifies market opportunities based on marketing analysis and forthcoming patent expiries, develops pharmaceutical formulations, advances projects to market approval stage, and assembles complete drug regulatory dossiers and licenses to be registered in countries where MIDPHARMA is active.

Apart from having a healthy pipeline for the generics, MIDPHARMA was one of the first manufacturers in Jordan to produce under license a biotechnology product which is the Recombinant Human Erythropoietin Epokine.

Additionally, we produce under a contract manufacturing agreement for various multinational companies.

RESEARCH & DEVELOPMENT

MIDPHARMA nurtures a culture for innovation and development, it is highly dependant on the support of it’s R&D to test and develop new formulations.

Generic pharmaceuticals are the bioequivalent of an originator, brand name product. This includes dosage forms, safety, strengths, routes of administration, quality, performance characteristics and intended use. MIDPHARMA’s generics are held to the same strict standards as the originator product, dictated by the U.S. Food and Drug Administration (FDA), Jordanian FDA, and other regulatory organizations throughout the world.

Our highly qualified R&D staff is supported by the latest equipment work to research our pipeline products, test the new formulations, and conduct all the required stability and biological studies .

03/12/2011 by MidPharma

QUALITY ASSURANCE & CONTROL…

MIDPHARMA implements a rigorous quality assurance system that starts with our R&D until the product is distributed to retailers.

Our Quality Control Department with its chemical and biological laboratories utilizes the latest equipments available on the market to perform assays, and our well trained staff is applying standards that comply with cGMP requirements and ISO standards.

The methodology applied at MIDPHARMA consists of :

American, British, and European pharmacopoeias
Our own validated methodology
Validation methods provided by licensing partners
ISO 9001/2000 standards

Our Quality Assurance Department carries out all the required activities to assure the optimum quality :

Chemical analysis department

Physical / chemical control of the pharmaceutical products :

Raw materials
Intermediate products
Packaging material
Chemical control of water
Maintenance and control of samples stores

Microbiology department

Microbiological control of water
Identification of micro-organisms
Environmental control of production areas
Microbiological control of pharmaceuticals :

Raw materials, Intermediate products, finished products, and Packaging material

03/12/2011 by MidPharma

MARKETING DEPARTMENT ..

MIDPHARMA is committed to practice its vision and mission through a group of qualified, well trained and highly motivated personnel in

the Marketing Department who are gathered to form a coherent team

Ability to think strategically and creativelycharacterized with their remarkable :

Excellent qualitative and quantitative analytical skills
Excellent communication and interpersonal skills
Results-oriented with willingness to take responsibility and initiative
Ability to work in a team environment

MIDPHARMA’s marketing team is responsible for :

Developing and implmenting short and long term strategic and tactical planning
Business planning and budget preparations
Assessing the market potential of products
Interpreting therapeutic market and promotional trends
Evaluating concepts for new advertising campaigns
Exploring trends with key customer types (e.g. health care providers and consumers)
Market research
Determining the appropriate positioning of products
Marketing communications